Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 02, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro to Present at H.C. Wainwright Global Life Science Conference

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
February 26, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Fourth Quarter and Year End 2020 Financial Results

Strengthened Industry-Centric Leadership Reorganization Initiated to Enhance Operations as Recro Expands Customer Portfolio, Explores Inorganic Growth Opportunities Core Commercial Product Outlook...
February 23, 2021 16:05 ET | Source: Recro Pharma, Inc.

Recro to Report Fourth Quarter and Year-End 2020 Financial Results Earlier Than Previously Announced

MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
February 23, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Announces Amendment to Athyrium Credit Facility

MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
February 19, 2021 16:05 ET | Source: Recro Pharma, Inc.

Recro to Report Financial Results for Fourth Quarter And Year-End 2020 on February 26

MALVERN, Pa., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
February 11, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Strengthens Leadership Team With Key Executive and Board Appointments

Company Names CDMO Industry Thought Leader, Jim Miller, to Board of Directors and Selects Ryan D. Lake as Dedicated Chief Financial OfficerRecent Appointments, including CEO David Enloe, Provide...
December 18, 2020 21:34 ET | Source: Recro Pharma, Inc.

Recro Grants Inducement Award to New Chief Executive Officer

MALVERN, Pa., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical...
December 16, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro Announces Executive Changes

MALVERN, Pa., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical...
November 09, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Third Quarter 2020 Financial Results

Company Secures Three-Year Renewal of License and Supply Agreement with Lannett, A Generics Pharmaceutical Company, for Manufacturing of Verelan PM®, Verelan SR® and Verapamil PM Strong Technical...
November 02, 2020 07:00 ET | Source: Recro Pharma, Inc.

Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020

MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation,...